> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FTC Hits First ‘iV Cocktails’ Seller
- URL: https://www.fdaweb.com/ftc-hits-first-iv-cocktails-seller/
- Published: 2018-09-21T12:00:00.000Z
- Updated: 2026-09-15T00:33:27.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142416

The FDA has charged A & O Enterprises (dba iV Bars), a seller of intravenously injected therapy products (iV Cocktails), with making a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart failure. This is the first company the FTC has targeted for such products. A [proposed FTC order settling the claims prohibits the company](https://www.ftc.gov/system/files/documents/cases/1723016%5Fiv%5Fbars%5Fdecision%5Forder%5F9-20-18.pdf?ref=fdaweb.com), which operates a string of clinics in Texas and Colorado, and its owner from making such claims, unless they can be supported by competent and reliable scientific evidence.

  
“The iV Cocktails, which were advertised as an alternative to traditional medical therapy, are actually a simple mix of water, vitamins, minerals, and herbs injected directly into the bloodstream for between $100 and $250 per ‘treatment,’” an [FTC release](https://www.ftc.gov/news-events/press-releases/2018/09/ftc-brings-first-ever-action-targeting-iv-cocktail-therapy?ref=fdaweb.com) says. “This enforcement action should send a clear message to the burgeoning iV therapy industry and sellers of all healthcare products,” FTC chair **Joe Simons** is quoted in the release as saying.